Suppr超能文献

金黄色葡萄球菌中诺氟沙星外排泵的2-芳基-1H-吲哚抑制剂的构效关系

Structure-activity relationships of 2-aryl-1H-indole inhibitors of the NorA efflux pump in Staphylococcus aureus.

作者信息

Ambrus Joseph I, Kelso Michael J, Bremner John B, Ball Anthony R, Casadei Gabriele, Lewis Kim

机构信息

School of Chemistry, University of Wollongong, Wollongong, NSW 2522, Australia.

出版信息

Bioorg Med Chem Lett. 2008 Aug 1;18(15):4294-7. doi: 10.1016/j.bmcl.2008.06.093. Epub 2008 Jul 2.

Abstract

The synthesis of 22 2-aryl-1H-indoles, including 12 new compounds, has been achieved via Pd- or Rh-mediated methodologies, or selective electrophilic substitution. All three methods were based on elaborations from simple indole precursors. SAR studies on these indoles and 2-phenyl-1H-indole in Staphylococcus aureus as NorA efflux pump inhibitors indicated 5-nitro-2-(3-methoxycarbonyl)phenyl-1H-indole was a slightly more potent inhibitor than the lead INF55. A promising new antibacterial lead compound against S. aureus (2-phenyl-1H-indol-5-yl)-methanol, was also found.

摘要

通过钯或铑介导的方法或选择性亲电取代反应,已经实现了22种2-芳基-1H-吲哚的合成,其中包括12种新化合物。所有这三种方法均基于简单吲哚前体的衍生化。对这些吲哚以及2-苯基-1H-吲哚作为金黄色葡萄球菌NorA外排泵抑制剂的构效关系研究表明,5-硝基-2-(3-甲氧基羰基)苯基-1H-吲哚是一种比先导化合物INF55稍强的抑制剂。还发现了一种有前景的新型抗金黄色葡萄球菌抗菌先导化合物(2-苯基-1H-吲哚-5-基)甲醇。

相似文献

1
Structure-activity relationships of 2-aryl-1H-indole inhibitors of the NorA efflux pump in Staphylococcus aureus.
Bioorg Med Chem Lett. 2008 Aug 1;18(15):4294-7. doi: 10.1016/j.bmcl.2008.06.093. Epub 2008 Jul 2.
2
Synthesis of functionalized 2-aryl-5-nitro-1H-indoles and their activity as bacterial NorA efflux pump inhibitors.
Bioorg Med Chem. 2006 Feb 1;14(3):857-65. doi: 10.1016/j.bmc.2005.09.019. Epub 2005 Oct 3.
3
1-(1H-indol-3-yl)ethanamine derivatives as potent Staphylococcus aureus NorA efflux pump inhibitors.
ChemMedChem. 2014 Jul;9(7):1534-45. doi: 10.1002/cmdc.201400042. Epub 2014 Mar 26.
5
Antibacterial activity of berberine-NorA pump inhibitor hybrids with a methylene ether linking group.
Bioorg Med Chem. 2009 Jun 1;17(11):3866-72. doi: 10.1016/j.bmc.2009.04.028. Epub 2009 Apr 19.
7
Novel synthetic bis-indolic derivatives with antistaphylococcal activity, including against MRSA and VISA strains.
J Antimicrob Chemother. 2015;70(6):1727-37. doi: 10.1093/jac/dkv015. Epub 2015 Feb 16.
8
1,3,4-oxadiazole conjugates of capsaicin as potent NorA efflux pump inhibitors of Staphylococcus aureus.
Bioorg Chem. 2021 Aug;113:105031. doi: 10.1016/j.bioorg.2021.105031. Epub 2021 May 27.
10
C-2 phenyl replacements to obtain potent quinoline-based NorA inhibitors.
J Enzyme Inhib Med Chem. 2020 Dec;35(1):584-597. doi: 10.1080/14756366.2020.1719083.

引用本文的文献

1
Small-molecule strategies to combat antibiotic resistance: mechanisms, modifications, and contemporary approaches.
RSC Adv. 2025 Jul 14;15(30):24450-24474. doi: 10.1039/d5ra04047g. eCollection 2025 Jul 10.
3
Medicinal Chemistry of Inhibitors Targeting Resistant Bacteria.
Curr Top Med Chem. 2022;22(24):1983-2028. doi: 10.2174/1568026622666220321124452.
4
Microbial Efflux Pump Inhibitors: A Journey around Quinoline and Indole Derivatives.
Molecules. 2021 Nov 19;26(22):6996. doi: 10.3390/molecules26226996.
5
Development of an Antibiotic Resistance Breaker to Resensitize Drug-Resistant : and Approach.
Front Cell Infect Microbiol. 2021 Aug 16;11:700198. doi: 10.3389/fcimb.2021.700198. eCollection 2021.
6
Antimicrobial Activities of New Indole Derivatives Containing 1,2,4-Triazole, 1,3,4-Thiadiazole and Carbothioamide.
Turk J Pharm Sci. 2018 Dec;15(3):291-297. doi: 10.4274/tjps.55707. Epub 2018 Nov 20.
7
Microbe-Derived Indole Metabolite Demonstrates Potent Multidrug Efflux Pump Inhibition in .
Front Microbiol. 2019 Sep 18;10:2153. doi: 10.3389/fmicb.2019.02153. eCollection 2019.
8
Design and synthesis of an indol derivative as antibacterial agent against .
J Chem Biol. 2017 Jun 8;10(4):159-177. doi: 10.1007/s12154-017-0173-0. eCollection 2017 Oct.
9
Recent Advances in Multi-Drug Resistance (MDR) Efflux Pump Inhibitors of Gram-Positive Bacteria S. aureus.
Antibiotics (Basel). 2013 Feb 5;2(1):28-45. doi: 10.3390/antibiotics2010028.
10
Clostridium difficile drug pipeline: challenges in discovery and development of new agents.
J Med Chem. 2015 Jul 9;58(13):5164-85. doi: 10.1021/jm5016846. Epub 2015 Mar 30.

本文引用的文献

2
Dual action-based approaches to antibacterial agents.
Curr Med Chem. 2007;14(13):1459-77. doi: 10.2174/092986707780831168.
4
Conjugating berberine to a multidrug efflux pump inhibitor creates an effective antimicrobial.
ACS Chem Biol. 2006 Oct 24;1(9):594-600. doi: 10.1021/cb600238x.
5
Waltzing transporters and 'the dance macabre' between humans and bacteria.
Nat Rev Drug Discov. 2007 Jan;6(1):56-65. doi: 10.1038/nrd2200. Epub 2006 Dec 8.
6
Synthesis of functionalized 2-aryl-5-nitro-1H-indoles and their activity as bacterial NorA efflux pump inhibitors.
Bioorg Med Chem. 2006 Feb 1;14(3):857-65. doi: 10.1016/j.bmc.2005.09.019. Epub 2005 Oct 3.
7
Multidrug resistance reversal agent from Jatropha elliptica.
Phytochemistry. 2005 Aug;66(15):1804-11. doi: 10.1016/j.phytochem.2005.06.008.
8
Bacterial efflux systems and efflux pumps inhibitors.
Biochimie. 2005 Dec;87(12):1137-47. doi: 10.1016/j.biochi.2005.04.012.
10
Efflux-mediated multiresistance in Gram-negative bacteria.
Clin Microbiol Infect. 2004 Jan;10(1):12-26. doi: 10.1111/j.1469-0691.2004.00763.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验